Clinical Trials Logo

Filter by:
NCT ID: NCT01399216 Completed - Clinical trials for Low Basal Body Temperature

Effects of a Supplement Containing Fucoidan on Basal Body Temperature

Start date: July 2011
Phase: N/A
Study type: Interventional

We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.

NCT ID: NCT01398956 Completed - Epilepsy Clinical Trials

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Start date: June 2011
Phase: Phase 3
Study type: Interventional

The investigators will provide Levetiracetam treatment to epilepsy subjects in Japan who are judged to benefit from continued treatment with Levetiracetam by the investigators and who are willing to continuously receive this drug.

NCT ID: NCT01398410 Completed - Clinical trials for Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin

Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Start date: December 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this study to examine the long-term safety of rabeprazole 5 mg or 10 mg tablets administered once daily in participants who were confirmed to have no recurrence of gastric or duodenal ulcer by endoscopic examination at the end of 24 weeks of treatment in the E3810-J081-308 (NCI01397448) [Double-Blind Phase] study. From a total of 420 participants who completed the E3810-J081-308 study, 328 entered the E3810-J081-309 (NCT01398410) study.

NCT ID: NCT01397955 Completed - Clinical trials for Osteoporosis, Postmenopausal

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Start date: January 2009
Phase: N/A
Study type: Observational

This study is a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Julina for postmenopausal osteoporosis. The objective of this study is to assess safety and efficacy of using Julina in clinical practice. A total 100 patients will be recruited and followed 3 years since starting Julina administration.

NCT ID: NCT01397786 Completed - Schizophrenia Clinical Trials

Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia

ZENITH
Start date: September 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the long-term safety, tolerability and efficacy of oral OPC-34712 as monotherapy in adults with schizophrenia.

NCT ID: NCT01397448 Completed - Clinical trials for Gastric or Duodenal Ulcers Caused by Low-dose Aspirin

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Start date: July 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this study to evaluate the effect of preventing recurrence of gastric or duodenal ulcers by administering E3810 5 mg or 10 mg tablets once daily or Teprenone 150 mg/day (50 mg three times daily) as a control to patients receiving low-dose aspirin and thereby examine the superiority of E3810 over Teprenone.

NCT ID: NCT01396421 Completed - Acute Schizophrenia Clinical Trials

Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia

VECTOR
Start date: July 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness, safety and tolerability of three different doses of OPC-34712 with placebo in the treatment of acute schizophrenia in adults.

NCT ID: NCT01396252 Completed - Depression Clinical Trials

Japanese Phase 1 Multiple Ascending Dose (MAD) Study

Start date: September 2011
Phase: Phase 1
Study type: Interventional

The purpose of this clinical study is to assess the safety and tolerability of multiple oral doses of BMS-820836 in healthy Japanese subjects and Japanese patients with depression.

NCT ID: NCT01395940 Completed - Endometriosis Clinical Trials

A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.

NCT ID: NCT01395810 Completed - Clinical trials for Congenital Bleeding Disorder

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

paradigmâ„¢ 4
Start date: April 15, 2012
Phase: Phase 3
Study type: Interventional

This trial is conducted in Asia, Europe, Japan, North America and South Africa. The aim is to evaluate the safety and efficacy of nonacog beta pegol (NNC-0156-0000-0009) after long-term exposure in patients with haemophilia B. This trial is an extension to trials NN7999-3747 (NCT01333111/paradigmâ„¢ 2) and NN7999-3773 (NCT01386528/paradigmâ„¢ 3).